Growth Metrics

Beta Bionics (BBNX) Receivables - Net (2023 - 2026)

Beta Bionics' Receivables - Net history spans 4 years, with the latest figure at $15.9 million for Q1 2026.

  • On a quarterly basis, Receivables - Net rose 75.56% to $15.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $15.9 million, a 75.56% increase, with the full-year FY2025 number at $17.3 million, up 42.62% from a year prior.
  • Receivables - Net hit $15.9 million in Q1 2026 for Beta Bionics, down from $17.3 million in the prior quarter.
  • Over the last five years, Receivables - Net for BBNX hit a ceiling of $17.3 million in Q4 2025 and a floor of $4.4 million in Q4 2023.
  • Historically, Receivables - Net has averaged $11.7 million across 4 years, with a median of $11.7 million in 2025.
  • Biggest five-year swings in Receivables - Net: soared 172.3% in 2024 and later soared 42.62% in 2025.
  • Tracing BBNX's Receivables - Net over 4 years: stood at $4.4 million in 2023, then soared by 172.3% to $12.1 million in 2024, then surged by 42.62% to $17.3 million in 2025, then dropped by 7.92% to $15.9 million in 2026.
  • Business Quant data shows Receivables - Net for BBNX at $15.9 million in Q1 2026, $17.3 million in Q4 2025, and $11.7 million in Q3 2025.